Our findings revealed that CXCL12 is highly expressed in PC1 subcluster, indicating that PC1 may activate specific inflammatory pathways in metastatic ESCC (Fig. 5c, d). The gene discussed is CXCL12; the disease is esophageal squamous cell carcinoma.